0001193125-26-182265.txt : 20260427 0001193125-26-182265.hdr.sgml : 20260427 20260427164104 ACCESSION NUMBER: 0001193125-26-182265 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20260427 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCA Healthcare, Inc. CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 273865930 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11239 FILM NUMBER: 26901651 BUSINESS ADDRESS: STREET 1: ONE PARK PLZ CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6153449551 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37203 FORMER COMPANY: FORMER CONFORMED NAME: HCA Holdings, Inc. DATE OF NAME CHANGE: 20101126 FORMER COMPANY: FORMER CONFORMED NAME: HCA INC/TN DATE OF NAME CHANGE: 20010627 FORMER COMPANY: FORMER CONFORMED NAME: HCA THE HEALTHCARE CO DATE OF NAME CHANGE: 20010419 8-K 1 hca-20260427.htm 8-K 8-K
false000086073000008607302026-04-272026-04-27

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 27, 2026

 

 

HCA Healthcare, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

1-11239

27-3865930

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

One Park Plaza

 

Nashville, Tennessee

 

37203

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 615 344-9551

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 Par Value

 

HCA

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 8.01 Other Events

On April 27, 2026, HCA Healthcare, Inc. (the “Registrant”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes (the “Offering”). The text of the Press Release is set forth as Exhibit 99.1 and is incorporated herein by reference.

On April 27, 2026, the Issuer provided notice of its election to redeem all $1.500 billion of its 5.250% senior notes due June 2026 (the “5.250% 2026 Notes”) and all $1.000 billion of its 5.375% senior notes due September 2026 (the “5.375% 2026 Notes” and, together with the 5.250% 2026 Notes, the “Redeemed Notes”). The Redeemed Notes will be redeemed on May 27, 2026 (the “Redemption Date”), conditioned upon the receipt prior to the Redemption Date by the Issuer of the net proceeds from the Offering. The redemption of the Redeemed Notes is being made pursuant to separately issued notices of redemption. This Current Report on Form 8-K does not constitute a notice of redemption of the Redeemed Notes.

Forward-Looking Statements

Information provided and statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this report and the Registrant assumes no obligation to update the information included in this report. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Registrant’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond the Registrant’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although the Registrant believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, results may prove to be materially different from the expectations expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Registrant’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Registrant with the Securities and Exchange Commission on February 10, 2026 and its other filings with the Securities and Exchange Commission. Unless otherwise required by law, the Registrant also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this report.

 

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits:

 

Exhibit 99.1

 

Press Release, dated April 27, 2026

 

 

 

Exhibit 104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

HCA HEALTHCARE, INC. (Registrant)

 

 

 

 

 

 

By:

/s/ John M. Franck II

 

 

 

John M. Franck II

 

 

 

Vice President – Legal and Corporate Secretary

 

Date: April 27, 2026

 

 EX-99.1 2 hca-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

 

 

img60930783_0.gif

 

 

 

 

 

 

 

FOR IMMEDIATE RELEASE

 

 

 

INVESTOR CONTACT:

 

MEDIA CONTACT:

Frank Morgan

 

Harlow Sumerford

615-344-2688

 

615-344-1851

 

HCA Announces Proposed PUBLIC Offering of Senior Notes

 

NASHVILLE, Tenn., April 27, 2026 – HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowings under its $4.000 billion commercial paper program (which may be reborrowed from time to time), and may use a portion of the net proceeds from this offering for the redemption of all or a portion of the $1.500 billion outstanding aggregate principal amount of its 5.250% senior notes due June 2026 and the $1.000 billion outstanding aggregate principal amount of its 5.375% senior notes due September 2026.

 

Citigroup Global Markets Inc., Barclays Capital Inc., BofA Securities, Inc., and J.P. Morgan Securities LLC are acting as the joint book-running managers for the offering.

 

The offering of the senior notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone: 1-800-831-9146 or by email: prospectus@citi.com; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at barclaysprospectus@broadridge.com or telephone at 1-888-603-5847; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, by email: dg.prospectus_requests@bofa.com or by telephone: 1-800-294-1322; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com.

 

You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.

 

This press release does not constitute an offer to sell or a solicitation of an offer to buy the senior notes or any other security or a notice of redemption of any 5.250% senior notes due June 2026 or 5.375% senior notes due September 2026 and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any notice of redemption of the 5.250% senior notes due June 2026 or the 5.375% senior notes due September 2026 will be made pursuant to separately issued notices of redemption.

 

 

FORWARD-LOOKING STATEMENTS

Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and HCA assumes no obligation to update the information included in this press release. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about HCA’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond HCA’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although HCA believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Company’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 10, 2026 and our other filings with the Securities and Exchange Commission. Unless otherwise required by law, HCA also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.

###

All references to the “Company” and “HCA” as used throughout this press release refer to HCA Healthcare, Inc.

and its affiliates.

 GRAPHIC 3 img60930783_0.gif GRAPHIC begin 644 img60930783_0.gif M1TE&.#EA_P)' ?< /___P ,P 9@ F0 S _P S S,P S9@ SF0 S MS S_P!F !F,P!F9@!FF0!FS !F_P"9 "9,P"99@"9F0"9S "9_P#, #, M,P#,9@#,F0#,S #,_P#_ #_,P#_9@#_F0#_S #__S, #, ,S, 9C, F3, MS#, _S,S #,S,S,S9C,SF3,SS#,S_S-F #-F,S-F9C-FF3-FS#-F_S.9 #.9 M,S.99C.9F3.9S#.9_S/, #/,,S/,9C/,F3/,S#/,_S/_ #/_,S/_9C/_F3/_ MS#/__V8 &8 ,V8 9F8 F68 S&8 _V8S &8S,V8S9F8SF68SS&8S_V9F &9F M,V9F9F9FF69FS&9F_V:9 &:9,V:99F:9F6:9S&:9_V;, &;,,V;,9F;,F6;, MS&;,_V;_ &;_,V;_9F;_F6;_S&;__YD )D ,YD 9ID F9D S)D _YDS )DS M,YDS9IDSF9DSS)DS_YEF )EF,YEF9IEFF9EFS)EF_YF9 )F9,YF99IF9F9F9 MS)F9_YG, )G,,YG,9IG,F9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G__\P ,P M,\P 9LP F

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end EX-101.SCH 4 hca-20260427.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 6 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Document And Entity Information
Apr. 27, 2026
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 27, 2026
Entity Registrant Name HCA Healthcare, Inc.
Entity Central Index Key 0000860730
Entity Emerging Growth Company false
Entity File Number 1-11239
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 27-3865930
Entity Address, Address Line One One Park Plaza
Entity Address, City or Town Nashville
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37203
City Area Code 615
Local Phone Number 344-9551
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 Par Value
Trading Symbol HCA
Security Exchange Name NYSE

XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports hca-20260427.htm hca-20260427.xsd http://xbrl.sec.gov/dei/2025 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "hca-20260427.htm": { "nsprefix": "hca", "nsuri": "http://www.hcahealthcare.com/20260427", "dts": { "inline": { "local": [ "hca-20260427.htm" ] }, "schema": { "local": [ "hca-20260427.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2025": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 22 }, "report": { "R1": { "role": "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_92518957-d931-460f-b876-b7afaf442ae7", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "h2", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "hca-20260427.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_92518957-d931-460f-b876-b7afaf442ae7", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "h2", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "hca-20260427.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://www.hcahealthcare.com/20260427/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0001193125-26-182265-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-26-182265-xbrl.zip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end XML 14 hca-20260427_htm.xml IDEA: XBRL DOCUMENT 0000860730 2026-04-27 2026-04-27 false 0000860730 8-K 2026-04-27 HCA Healthcare, Inc. DE 1-11239 27-3865930 One Park Plaza Nashville TN 37203 615 344-9551 false false false false Common Stock, $0.01 Par Value HCA NYSE false